Key points are not available for this paper at this time.
Within the limitations of the present study, regenerative therapy using either EMD + DBBM or CM + DBBM yielded comparable clinical outcomes in deep non-contained intrabony defects after 12 months.
Iorio‐Siciliano et al. (Fri,) studied this question.